Total Birth Control Market By Method (Hormonal Intrauterine Device, Copper Intrauterine Device, Combination Oral Contraceptives, Progestin Only Oral Contraceptives, Injectable Contraceptives, Birth Control Implants, Vaginal Rings, Diaphragms, Male Condoms, Female Condoms, and Others), By End User (Hospitals, Gynaecology Clinics, Community Health Care Centers, Online Channel, Public Channel, and Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Total Birth Control Market size was valued at USD billion in 2022 and is poised to grow at a significant CAGR of 6% over 2023-2029.  The World Health Organization (WHO) estimates that 16 million girls between the ages of 15 and 19 give birth yearly, or about 11% of all births worldwide. Its Your Life, It's Your Future by the WHO and World Contraception Day are only two examples of international awareness campaigns that have been started to stop these unintended pregnancies. Governments, international organizations, and other private sector organizations were asked to commit to increasing access to voluntary family planning during the London Summit on Family Planning. Family Planning 2020, a global alliance, was born out of this (FP2020). Global momentum has been generated by FP2020 on topics like access to contraception, more innovation, and improved accountability in family planning initiatives. For instance, India will have spent USD 3 billion by 2020 to increase family planning and knowledge in the nation.

Additionally, the United Nations Department of Economic and Social Affairs estimates that 1.1 billion women between the ages of 15 and 49 will need family planning worldwide in 2020. The increased use of contraception has improved health-related outcomes, including maternal and infant mortality, and decreased the risk of sexually transmitted infections. In addition, a rise in the number of gynecologists using these contraceptive methods for birth control is anticipated to drive industry growth in the ensuing years. Increased usage of safe and effective oral pills, awareness of modern contraceptives, and health issues associated with teen pregnancies all contribute to the market forecasts for contraceptives. Significant businesses, including Cooper Companies, Veru Inc., Pfizer Inc., and others, are implementing the acquisition strategy to sustain competitiveness in the market. For example, in March 2021, Cooper finalized the acquisition of a privately held medical device firm that created and developed an innovative obstetric product for use in urgent obstetrics to lower birthing risks, which is likely to generate a market opportunity for contraceptives.

Total Birth Control Market Key Developments:
  • In January 2020, Sandoz acquired the Aspen's Japanese operations, strengthening its position in world’s third largest market for generics and off-patent medicines and it also expand portfolio and pipeline of hospital generic and biosimilar products
  • In Japan, In May 2020, AbbVie acquired Allergan company, Allergan is a global pharmaceutical leader focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. AbbVie's existing product portfolio and pipeline is enhanced with numerous Allergan assets and Allergan's product portfolio benefits from AbbVie's commercial strength, expertise and international infrastructure.

Total Birth Control Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Total Birth Control Market Dynamics

An increase in the prevalence of sexually transmitted diseases (STDs) is anticipated to boost market demand. Numerous studies have looked into how well various forms of contraception, such as tablets, patches, and rings. Work to prevent STDs. In addition, the WHO is working hard to improve and integrate services for contraception and the prevention of sexually transmitted infections to lower the incidence of these diseases. Many governmental and non-governmental organizations emphasize investments that will raise awareness of and give attention to sexual health. On the other hand, contraceptive pill side effects are a significant worry that could impede the market growth.

Key Features of the Reports

  • The total birth control market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Total Birth Control Market Segmentation

By Method
  • Hormonal Intrauterine Device
  • Copper Intrauterine Device
  • Combination Oral Contraceptives
  • Progestin Only Oral Contraceptives
  • Implants
  • Vaginal Rings
  • Others
By End Users
  • Hospitals
  • Gynaecology Clinics
  • Community Health Care Centers
  • Homecare and Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

The total birth control market is projected to expand at a CAGR of 6% during the forecast period

Allergan, Mylan N.V., Bayer AG, Sandoz, The Cooper Companies Inc., Pfizer, Inc., Merck, DKT International, Afaxys, Inc., Syneos Health,Agile Therapeutics

North America is the fastest-growing region for  total birth control market

1.Executive Summary
2.Global Total Birth Control Market Introduction 
2.1.Global Total Birth Control Market  - Taxonomy
2.2.Global Total Birth Control Market  - Definitions
2.2.1. By Method
2.2.2. By End User
2.2.3.By Region
3.Global Total Birth Control Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Total Birth Control Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Total Birth Control Market  By Method, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Hormonal Intrauterine Device
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Copper Intrauterine Device
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Combination Oral Contraceptives
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Progestin Only Oral Contraceptives
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Implants
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Vaginal Rings
5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Total Birth Control Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Gynaecology Clinics
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Community Health Care Centers
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Homecare and Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Total Birth Control Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Total Birth Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Method Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Hormonal Intrauterine Device
8.1.2.Copper Intrauterine Device
8.1.3.Combination Oral Contraceptives
8.1.4.Progestin Only Oral Contraceptives
8.1.5.Implants
8.1.6.Vaginal Rings
8.1.7.Others
8.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Gynaecology Clinics
8.2.3.Community Health Care Centers
8.2.4.Homecare and Others
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Total Birth Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Method Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hormonal Intrauterine Device
9.1.2.Copper Intrauterine Device
9.1.3.Combination Oral Contraceptives
9.1.4.Progestin Only Oral Contraceptives
9.1.5.Implants
9.1.6.Vaginal Rings
9.1.7.Others
9.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Gynaecology Clinics
9.2.3.Community Health Care Centers
9.2.4.Homecare and Others
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Total Birth Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Method Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Hormonal Intrauterine Device
10.1.2.Copper Intrauterine Device
10.1.3.Combination Oral Contraceptives
10.1.4.Progestin Only Oral Contraceptives
10.1.5.Implants
10.1.6.Vaginal Rings
10.1.7.Others
10.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Gynaecology Clinics
10.2.3.Community Health Care Centers
10.2.4.Homecare and Others
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Total Birth Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Method Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Hormonal Intrauterine Device
11.1.2.Copper Intrauterine Device
11.1.3.Combination Oral Contraceptives
11.1.4.Progestin Only Oral Contraceptives
11.1.5.Implants
11.1.6.Vaginal Rings
11.1.7.Others
11.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Gynaecology Clinics
11.2.3.Community Health Care Centers
11.2.4.Homecare and Others
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Total Birth Control Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Method Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Hormonal Intrauterine Device
12.1.2.Copper Intrauterine Device
12.1.3.Combination Oral Contraceptives
12.1.4.Progestin Only Oral Contraceptives
12.1.5.Implants
12.1.6.Vaginal Rings
12.1.7.Others
12.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Gynaecology Clinics
12.2.3.Community Health Care Centers
12.2.4.Homecare and Others
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Allergan
13.2.2.Mylan N.V.
13.2.3.Bayer AG
13.2.4.Sandoz
13.2.5.The Cooper Companies Inc.
13.2.6.Pfizer, Inc.
13.2.7.Merck
13.2.8.DKT International
13.2.9.Afaxys, Inc.
13.2.10.Syneos Health
13.2.11.Agile Therapeutics
14. Research Methodology 
15. Appendix and Abbreviations 
  • Allergan
  • Mylan N.V.
  • Bayer AG
  • Sandoz
  • The Cooper Companies Inc.
  • Pfizer, Inc.
  • Merck
  • DKT International
  • Afaxys, Inc.
  • Syneos Health
  • Agile Therapeutics

Adjacent Markets